Oncology
14 drugs are in development for Melanoma.
- Companies
- 8
- Clinical trials
- 130
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Melanoma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(2)
| Drug | Company |
|---|---|
| Entinostat | Syndax Pharmaceuticals Inc (SNDX) |
| ngm120 | NGM BIOPHARMACEUTICALS INC (NGM) |
Phase 1(10)
| Drug | Company |
|---|---|
| AB308 | Arcus Biosciences, Inc. (RCUS) |
| CFT1946 | C4 Therapeutics, Inc. (CCCC) |
| CTX-471 | Compass Therapeutics, Inc. (CMPX) |
| tsc-200-a0201 | TScan Therapeutics, Inc. (TCRX) |
| tsc-201-b0702 | TScan Therapeutics, Inc. (TCRX) |
| tsc-202-a0201 | TScan Therapeutics, Inc. (TCRX) |
| tsc-203-a0201 | TScan Therapeutics, Inc. (TCRX) |
| tsc-204-a0101 | TScan Therapeutics, Inc. (TCRX) |
| tsc-204-a0201 | TScan Therapeutics, Inc. (TCRX) |
| tsc-204-c0702 | TScan Therapeutics, Inc. (TCRX) |
Phase 1/Phase 2(2)
About this indication
Melanoma context
Oncology·MeSH: Melanoma (D008545)
Also known as: Malignant Melanomas, Melanoma, Malignant, Melanomas
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Melanoma?
BioSniper tracks 14 drugs in development for Melanoma across 8 companies.
How many clinical trials target Melanoma?
There are 130 clinical trials targeting Melanoma tracked by BioSniper.
What is the prevalence of Melanoma?
The estimated prevalence of Melanoma is approximately 75.0 per 100,000 population.